Progressive Muscular Dystrophy (Duchenne Type) (Case Report)

  • Soelatin Winarno Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java
  • Indrawarman Indrawarman Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java
  • Sabdo Waloejo Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java
  • Lydia Kristianti Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java
DOI: https://doi.org/10.14238/pi16.9-10.1976.361-4
Keywords: progressive muscular dystrophy; Duchenne type; sexlinked; pseudohypertrophyic type

Abstract

Clinical findings of two brothers suffering from progressive muscular dystrophy pseudohypertrophic type according to Duchenne are reported. Literatures dealing with its clinical classification, biochemical disturbances, hypotheses of the pathogenesis, management of treatment, mode of action of A.T.P. and the pedigree have been briefly reported.

Progressive Muscular Dystrophy is a progressive disease affecting voluntary muscles; It is characterized by a decreased strength in the affected muscles with rapid or slow gradual progression. About 45% of the patients gave a history that at least another member of the family is affected by the disease. Pseudohypertrophic form (Duchenne type) is usually inherited as a recessive factor, often sexlinked.

Published
2019-09-17
How to Cite
1.
Winarno S, Indrawarman I, Waloejo S, Kristianti L. Progressive Muscular Dystrophy (Duchenne Type) (Case Report). PI [Internet]. 17Sep.2019 [cited 23Nov.2024];16(9-10):361-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2311
Issue
Vol 16 No 9-10 (1976): September - October 1976
Section
Case Report

Copyright (c) 2019 Soelatin Winarno, Indrawarman Indrawarman, Sabdo Waloejo, Lydia Kristianti

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Received 2019-09-17
Published 2019-09-17